Intra-and extracellular susceptibility of 35 clinically isolated Mycobacterium avium-intracellulare strains to cefotaxime (CTX), ceftizoxime (CZX), and cefoperazone was studied. MICs for 50% of the isolates in vitro were 6.25 ,Ig/mI for CTX and CZX and 25 ,ug/ml for cefoperazone. A strain susceptible to CTX (MIC, 0.78 ,ug/ml) and CZX (MIC, 1.56 ,ug/ml) infected human peripheral blood mononuclear cells in the presence of 20% autologous plasma. The mycobacteria replicated exclusively in monocytes under the above culture condition. Concentrations of CZX 1-to 16-fold higher than its in vitro MIC had little effect on intracellular replication of the strain. A concentration of CTX 16-fold higher than its in vitro MIC was bacteriostatic to the mycobacteria, but CTX of lower concentrations showed no effect on intracellular replication. Thus, ineffectiveness of the cephems on the therapy of M. avium-intracellulare infection was suggested.
Since Mycobacterium avium-intracellulare is resistant to most antitubercle agents, the current therapy for this infection is disappointing (2-4, 9-11). We look for agents effective against this organism among nonantitubercle drugs. Thirdgeneration cephem antibiotics were studied in this report. The susceptibility of 35 clinically isolated M. avium-intracellulare strains to cefoperazone (CPZ), cefotaxime (CTX), and ceftizoxime (CZX) was tested in FST medium (8) (Fig. 1) . MICs of CPZ, CTX, and CZX for 90% of the isolates were 25, 6 .25, and 6.25 pug/ml, respectively. It was reported that five strains of M. avium-intracellulare isolated from acquired immune deficiency syndrome patients were all resistant to 10 ,ug of CPZ per ml (3), coinciding with our result. Latamoxef, another third-generation cephem, was found to be the least effective (MIC, 200 ,ug/ml) compared with the three cephems and was omitted from Fig. 1 
Tween-free FST medium. Each cell suspension (0.1 ml) was plated in a 96-well tray. Resulting colonies of mycobacteria were counted under a microscope after a 5-day incubation (7) . In the absence of CZX, 5.2 ± 0.5 x 103 CFU of Jll cells on day 1 increased to 2.5 ± 0.1 x 104 CFU on day 8 (Fig. 2) . With 1.56 to 6.25 ,ug of CZX per ml (1 to 4x MIC), Jll cells replicated to almost the same extent as without the antibiotic. With 12.5 to 25 ,ug of CZX per ml (8 to 16x MIC), Jll cells also proliferated, although the growth rate slightly decreased. Thus, even a 16-times-higher concentration of CZX than its in vitro MIC failed to inhibit the replication of M. avium-intracellulare in human monocytes. This experiment also indicated that infecting mycobacteria had replicated intracellularly but not extracellularly under the culture condition, confirming our previous result (7) . Similarly, strain T1l, which was most susceptible to CTX (MIC, 0.78 jig/ml), infected mononuclear cells were treated with indicated concentrations of CTX on day 1 and cultivated as above. With 0.78 to 6.25 ,ug of CTX per ml (1 to 8x MIC), intracellular replication of T1l was not greatly inhibited (Fig.  3) . With 12.5 ,ug of CTX per ml, however, viable cells of T1l on day 8 decreased below that on day 1, indicating that a concentration of CTX 16 times higher than its in vitro MIC was bacteriostatic to intracellular mycobacteria. Since the in vitro MIC of CZX and CTX for 90% of 35 strains of clinically isolated M. avium-intracellulare was 12.5 ,ug/ml (Fig. 1) , we suspect that these cephems are therapeutically effective on the mycobacterial infection.
Of four cephems tested for M. avium-intracellulare infection, two (latamoxef and CPZ) were excluded after the in vitro susceptibility testing. The survived cephems were further tested for their effect on two mycobacterial strains resided in human monocytes. However, even 10-timeshigher concentrations of the cephems than their in vitro MICs exhibited no quite different from that of aminoglycoside antibiotics; their intracellular MICs are comparable to their extracellular MICs (7) . A possible reason that cephems had no effect on intracellular parasites is that they are poorly permeated into mononuclear phagocytes. CZX and CTX reversibly binds to human plasma (as much as 30 and 70%, respectively) (1, 6). It is not known whether plasma affects the permeability of the cephems. Another possibility is that human monocytic cells have enzymes with some cephalosporinase activity. It is essential to elucidate those possibilities for the chemotherapeutical use of cephems in mycobacterial infection.
